Intensity Modulated Radiation Therapy and Cisplatin in Treating Patients with Stage I-IVA Cervical Cancer

October 21, 2015 -

This partially randomized phase II/III trial studies how well intensity modulated radiation therapy (IMRT) works and compares it to conventional radiation therapy in treating patients with stage I-IVA cervical cancer. Radiation therapy uses high-energy X-rays and other types of radiation to kill tumor cells.

Specialized radiation therapy that delivers a high dose of radiation directly to the tumor may kill more tumor cells and cause less damage to normal tissue. Drugs used in chemotherapy, such as cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. It is not yet known whether IMRT is more effective than conventional radiation therapy in treating cervical cancer.

To learn more CLICK HERE.



If you would like to speak to us about how you can become involved with our foundation, become a sponsored family, or just need general information, please submit the form below and one of our team members will contact you promptly.